Clinical Trial Update: Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma [Phase 1]

View source ↗

Summary

Global Phase 1 study to assess the safety and tolerability of AZD1208 in patients with advanced solid tumors and malignant lymphoma; the study is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• AZD1208

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Malignancies, Malignant Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2015-08-19